INFLUENCE OF CYP2C19 GENOTYPE AND SERUM PEPSINOGEN LEVEL ON FIRST-LINE ERADICATION THERAPY WITH ESOMEPRAZOLE FOR PATIENTS WITH HELICOBACTER PYLORI-POSITIVE GASTRITIS
Yoshimasa Saito 1
Hiroshi Serizawa 2
Yukako Kato 2
Masaru Nakano 3
Masahiko Nakamura
HIDEKAZU SUZUKI
Hidetsugu Saito
1 Division Of Pharmacotherapeutics, Keio University Faculty Of Pharmacy, Tokyo, Japan;division Of Gastroenterology, Kitasato Institute Hospital, Tokyo, Japan
2 Division Of Gastroenterology, Kitasato Institute Hospital, Tokyo, Japan
3 Division Of Gastroenterology, Kitas
Conference
UEG Week 2014
Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu
Social Sharing